Varaico: Literature-Extracted Genetic Variants

Gene:OTC
Variant:p.N161S
Back to variants list

OTC

NM_000531.6:p.N161S

Associated Papers

Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency and in silico analysis of OTC gene.

Zhang Y et al.

Orphanet Journal of Rare Diseases, 2025

40102887 (PubMed )
Supplement: 13023_2025_3624_MOESM2_ESM.docx

Liver transplantation in ornithine transcarbamylase deficiency: A retrospective multicentre cohort study.

Seker Yilmaz B et al.

Molecular Genetics and Metabolism Reports, 2023

Newborn ornithine carbamyltransferase deficiency caused by new OTC gene mutations: a report of two cases and review of the literature on phenotype and genotype.

Yu A et al.

Translational Pediatrics, 2023

37969118 (PubMed )
Supplement: tp-12-10-1887-prf.pdf

Dosage Compensation in Females with X-Linked Metabolic Disorders.

Juchniewicz P et al.

International Journal of Molecular Sciences, 2021

33925963 (PubMed )
Supplement: ijms-22-04514-s001.zip › Supplementary_File_Table_S2.pdf

Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency.

Lu D et al.

Orphanet Journal of Rare Diseases, 2020

[Genetic testing and prenatal diagnosis in seven pedigrees affected with ornithine transcarbamylase deficiency].

Liu N et al.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2020

Hemodynamics of Prefrontal Cortex in Ornithine Transcarbamylase Deficiency: A Twin Case Study.

Anderson AA et al.

Frontiers in Neurology, 2020

Mitochondrial Enzymes of the Urea Cycle Cluster at the Inner Mitochondrial Membrane.

Haskins N et al.

Frontiers in Physiology, 2020

33551825 (PubMed )
Supplement: Data_Sheet_1.zip › SupplementaryData_DataSheet › Supplementary_Tables_S1-S6.xlsx › Table_S4

The phenotypic and mutational spectrum of Thai female patients with ornithine transcarbamylase deficiency.

Chongsrisawat V et al.

Gene, 2018

Clinical and mutation analysis of 24 Chinese patients with ornithine transcarbamylase deficiency.

Shao Y et al.

Clinical Genetics, 2017

Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.

Choi JH et al.

Journal of Human Genetics, 2015

Computational pipeline to identify and characterize functional mutations in ornithine transcarbamylase deficiency.

Magesh R et al.

3 Biotech, 2014

Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.

Martín-Hernández E et al.

Orphanet Journal of Rare Diseases, 2014

[Clinical characteristics and analysis of mass spectrometric data in patients with ornithine transcarbamylase deficiency].

Han F et al.

Zhonghua Yi Xue Za Zhi, 2014

OTC gene in ornithine transcarbamylase deficiency: clinical course and mutational spectrum in seven Korean patients.

Lee JH et al.

Pediatric Neurology, 2014

[Comparison and clinical application of two methods for determination of plasma chitotriosidase activity].

Wang Y et al.

Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics, 2012

Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids.

Lipskind S et al.

Journal of Perinatology : Official Journal of the California Perinatal Association, 2011

High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH.

Shchelochkov OA et al.

Molecular Genetics and Metabolism, 2009

Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.

Arranz JA et al.

Journal of Inherited Metabolic Disease, 2007

Identification of novel mutations in the human ornithine transcarbamylase (OTC) gene of Korean patients with OTC deficiency and transient expression of the mutant proteins in vitro.

Kim GH et al.

Human Mutation, 2006

Cultured fibroblasts as a tool for improvement of molecular analysis in ornithine transcarbamylase (OTC) deficiency.

Häberle J et al.

Human Mutation, 2003

Genetic analysis in nine unrelated Italian patients affected by OTC deficiency: detection of novel mutations in the OTC gene.

Bisanzi S et al.

Molecular Genetics and Metabolism, 2002

Genetic analysis of carbamoylphosphate synthetase I and ornithine transcarbamylase deficiency using fibroblasts.

Rapp B et al.

European Journal of Pediatrics, 2001

The biochemical and molecular spectrum of ornithine transcarbamylase deficiency.

Tuchman M et al.

Journal of Inherited Metabolic Disease, 1998

Relative frequency of mutations causing ornithine transcarbamylase deficiency in 78 families.

Tuchman M et al.

Human Genetics, 1996

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."